Harnessing radiation to see and treat cancer
Telix Pharmaceuticals (telixpharma.com) scores 75 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, in the 42nd percentile of 12467 Healthcare brands.
Telix Pharmaceuticals is an Australian public company operating in the healthcare sector, focused on oncology. It develops targeted radiopharmaceutical therapies, precision imaging agents, and AI-enabled surgical solutions designed to detect, characterize, and treat cancer. Telix serves cancer patients, oncologists, radiologists, and healthcare providers involved in diagnosing and treating urologic, neurologic, and other solid tumor cancers. Its stated mission is to help patients with cancer live longer with better quality lives.
| Brand Name | Telix Pharmaceuticals |
|---|---|
| Domain | telixpharma.com |
| Industry | Healthcare |
| Headquarters | Australia |
| Main Competitors | Novartis (Advanced Accelerator Applications) (71/100), Lantheus Holdings (80/100), Curium Pharma (79/100), Bayer (Radiopharmaceuticals) (79/100), Fusion Pharmaceuticals, POINT Biopharma (70/100), Blue Earth Diagnostics (74/100) |
Moz Domain Authority 40/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
Ranked #548,948 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Our mission is to help patients with cancer live longer with better quality lives" (Meta description: 14 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, React.
Social footprint: verified profiles on X (Twitter), LinkedIn, Instagram, YouTube; no detected presence on Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Telix Pharmaceuticals?", Claude could identify the brand as of August 2026. Telix Pharmaceuticals is an Australian biopharmaceutical company focused on developing and commercializing radiopharmaceuticals for the diagnosis and treatment of cancer and other serious diseases. Its most notable product is Illuccix, a prostate-specific membrane antigen (PSMA) Best known for Developing Illuccix, a PSMA-targeted PET imaging agent for prostate cancer diagnosis.
When asked "Best brands similar to Telix Pharmaceuticals?", Claude would recommend Telix Pharmaceuticals as of August 2026. Telix is a recognized player in the growing radiopharmaceutical and precision oncology space, making it relevant to mention alongside companies like Novartis (radioligand therapy) or Lantheus.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Telix Pharmaceuticals's main competitors in Healthcare: Novartis (Advanced Accelerator Applications) (71/100), Lantheus Holdings (80/100), Curium Pharma (79/100), Bayer (Radiopharmaceuticals) (79/100), POINT Biopharma (70/100).
Sources: Brand Analyzer scan
Telix Pharmaceuticals has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 26, trust 40, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals offers targeted radiopharmaceutical therapies for cancer treatment, precision imaging agents for cancer diagnosis and characterization, and AI-enabled surgical solutions. These offerings are designed to support the full patient journey from detection through treatment, particularly for urologic, neurologic, and other solid tumor cancers.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals is an Australian public company in the healthcare industry that specializes in oncology. It develops targeted radiopharmaceutical therapies and precision imaging agents, along with AI-enabled surgical solutions, aimed at improving the detection, characterization, and treatment of cancer.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals develops and integrates targeted radiopharmaceutical therapies, precision imaging agents, and AI-enabled surgical technologies to help detect, characterize, and treat cancer across the patient journey. Its work spans urologic, neurologic, and other solid tumor cancers, supporting oncologists and radiologists in diagnosis and treatment planning.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals' products and services are used by cancer patients, along with oncologists, radiologists, and other healthcare providers involved in diagnosing and treating urologic, neurologic, and other solid tumor cancers.
Sources: Telix Pharmaceuticals official site
Telix Pharmaceuticals scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Telix Pharmaceuticals has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (26/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #548,948 (Tranco) and a Moz Domain Authority of 40/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Telix Pharmaceuticals from memory (August 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Telix Pharmaceuticals: Teijin (75/100), The Dentists Supply Company (TDSC.com) (75/100), PerfectServe (75/100), TempGenius (75/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.